OR WAIT null SECS
January 17, 2019
Univercells, a business-to-business provider focused on biologics, has commercially launched its proprietary bioproduction system, NevoLine.
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has made two significant changes to its new 2019 Code of Practice with the aim of boosting business integrity on a global scale.
Cell and gene therapy platform company, Locate Bio, has announced that it is set to receive key patents for its IntraStem technology covering the United States and Europe
Lonza and Takeda have furthered their multiproduct partnership through collaborative efforts on a new cancer treatment-Alunbrig (brigatinib).
The Centre for Process Innovation (CPI) has led an Innovate UK project focused on the establishment of a generic framework and core capability to improve industrial productivity using computer models.
Almac Sciences has announced the expansion of its technology capabilities within its API services and chemical development portfolio through implementation of continuous flow expertise.
January 16, 2019
The United Kingdom’s government has emphatically voted against the Prime Minister’s proposed withdrawal deal in the largest defeat the House of Commons has faced in its history. So, what is next for Brexit and, in particular, the pharma industry?
January 03, 2019
Pharmaceutical Technology spoke with Steve Tallant, Systech, about the UniSecure solution, which won the 2018 CPhI Excellence in Pharma Award for supply chain, logistics, and distribution.
January 02, 2019
As Brexit rapidly approaches, the lack of clarity around the regulatory balance between the regions could lead to a reduction in standards.
January 01, 2019
This coming year could see a combination of regulatory uncertainty and inactivity for the pharma industry, mainly as a result of Brexit.